Pharmacokinetics of Indinavir Combined with Low-Dose Ritonavir in Human Immunodeficiency Virus Type 1-Infected Children

So far, no pediatric doses for indinavir combined with ritonavir have been defined. This study evaluated the pharmacokinetics of 400 mg of indinavir/m(2) combined with 125 mg of ritonavir/m(2) every 12 h (q12h) in 14 human immunodeficiency virus type 1-infected children. The area under the concentra...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Bergshoeff, A. S., Fraaij, P. L. A., van Rossum, A. M. C., Verweel, G., Wynne, L. H., Winchell, G. A., Leavitt, R. Y., Nguyen, B.-Y. T., de Groot, R., Burger, D. M.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2004
Sujets:
Antiviral Agents
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC400593/
https://ncbi.nlm.nih.gov/pubmed/15105157
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.48.5.1904-1907.2004
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires